Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects

Journal of Interferon and Cytokine Research

Volumn 25, Issue 9, 2005, Pages 547-552

  Antonelli, Alessandro ^a,d   Rotondi, Mario ^b   Fallahi, Poupak ^a   Romagnani, Paola ^c   Ferrari, Silvia Martina ^a   Ferrannini, Ele ^a   Serio, Mario ^c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; AUTOANTIBODY; CHOLESTEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 8; LIGAND; LOW DENSITY LIPOPROTEIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGING; CHEMOKINES, CXC; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROID DISEASES;

EID: 25844487672     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.547     Document Type: Article

References (42)

1. Martin GR, Danner B, Holbrook NJ. Aging-causes and defenses. Annu Rev Med. 1993;44:419-429.
2. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
3. Linton PJ, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector alterations with aging. Immunol Rev. 1997;160:9-18.
4. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today. 1995;16:12-16.
5. Franceschi C, Bonafé M, Valensin S, Olivieri F, De Luca M, Ottavini E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci. 2000;908:244-262.
6. Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mech Ageing Dev. 2002;123:975-985.
7. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 1998;102:199-209.
8. Stephan RP, Lill-Elghanian DA, Witte PL. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J Immunol. 1997;158:1598-1609.
9. Zlotnik A, Yoshle O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
10. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56.
11. Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet. 1997;349:490-495.
12. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M. Expression of IP-10/CXCL10 and Mig/CXCL9 in the thyroid and increased serum levels of IP-10/CXCL10 in the serum of subjects with recent onset Graves' disease. Am J Pathol. 2002;161:195-206.
13. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M. High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab. 2004;89:5496-5499.
14. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E, Serio M. Increase of interferon-γ inducible α chemokine CXCL10 but not β chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol. 2005;152:171-177.
15. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K, Messina A, Gomis R. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia. 2002;45:1107-1110.
16. + lymphocytes. J Clin Endocrinol Metab. 2001;86:5008-5016.
17. Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-γ inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest. 2003;26:177-180.
18. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
19. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26:189-218.
20. Taub DD, Oppenheim JJ. Review of the chemokine meeting the Third International Symposium of Chemotactic Cytokines. Cytokine. 1993;5:175-179.
21. Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab. 1999;84:435-439.
22. Antonelli A, Miccoli P, Fallahi P, Grosso M, Nesti C, Spinelli C, Ferrannini E. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid. 2003;13:479-484.
23. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La Villa G, Serio M, Bertoni E, Salvadori M, Romagnani P. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant. 2004;4:1466-1474.
24. Lisignoli G, Piacentini A, Toneguzzi S, Grassi F, Tschon M, Cristino S, Facchini A, Mariani E. Age-associated changes in functional response to CXCR3 and CXCR5 chemokine receptors in human osteoblasts. Biogerontology. 2003;4:309-317.
25. Mysliwska J, Bryl E, Foerster J, Mysliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Dev. 1998;100:313-328.
26. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23:2375-2378.
27. Krampera M, Vinante F, Tavecchia L, Morosato L, Chilosi M, Romagnani S, Zanolin ME, Pizzolo G. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol. 1999;117:291-297.
28. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, Di Gioacchino M, Cesarotti ME, Doni A, Mantovani A, Franceschi C, Paganelli R. Chemokines, sTNF/Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev. 2000;121:37-46.
29. Pulsatelli L, Meliconi R, Mazzetti I, Dolzani P, Meneghetti A, Neri S, Silvestri T, Ravaglia G, Forti P, Facchini A, Mariani E. Chemokine production by peripheral blood mononuclear cells in elderly subjects. Mech Ageing Dev. 2000;121:89-100.
30. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res. 1999;19:1179-1182.
31. Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 1992;51:1953-1956.
32. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol. 1993;150:5219-5230.
33. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993;90:10193-10197.
34. Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-kappaB p65 (RelA) and NF-IL-6. J Immunol. 1994;153:153-164.
35. Pang BS, Wang Z, Zhang LM, Tong ZH, Xu LL, Huang XX, Guo WJ, Zhu M, Wang C, Li XW, He ZP, Li HX, Zhao FJ. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J [Engl]. 2003;116:1283-1287.
36. Freire Ade L, Bertolo MB, de Pinho AJ Jr, Samara AM, Fernandes SR. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet's disease. Clin Rheumatol. 2004;23:203-205.
37. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Corsi MP, Quaglino D. The immune system in the elderly: I. Specific humoral immunity. Immunol Res. 1999;20:101-108.
38. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Martorelli V, Quaglino D. The immune system in the elderly: II. Specific cellular immunity. Immunol Res. 1999;20:109-115.
39. Shearer GM. Th1/Th2 changes in aging. Mech Ageing Dev. 1997;94:1-5.
40. Ide K, Hayakawa H, Yagi T, Sato A, Koide Y, Yoshida A, Uchijima M, Suda T, Chida K, Nakamura H. Decreased expression of Th2 type cytokine mRNA contributes to the lack of allergic bronchial inflammation in aged rats. J Immunol. 1999;163:396-402.
41. Li SP, Miller RA. Age-associated decline in IL-4 production by murine T lymphocytes in extended culture. Cell Immunol. 1993;151:187-195.
42. + T cells with ageing. Clin Exp Immunol. 2000;120:267-273.